Forouzannia, F., Hamadeh, A., Passos‐Castilho, A. M., Erman, A., Yu, A., Feng, Z., . . . Wong, W. W. L. (2024). Impact of new direct‐acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection. Liver International, 44(6), 1383. https://doi.org/10.1111/liv.15875
Chicago Style (17th ed.) CitationForouzannia, Farinaz, et al. "Impact of New Direct‐acting Antiviral Therapy on the Prevalence and Undiagnosed Proportion of Chronic Hepatitis C Infection." Liver International 44, no. 6 (2024): 1383. https://doi.org/10.1111/liv.15875.
MLA (9th ed.) CitationForouzannia, Farinaz, et al. "Impact of New Direct‐acting Antiviral Therapy on the Prevalence and Undiagnosed Proportion of Chronic Hepatitis C Infection." Liver International, vol. 44, no. 6, 2024, p. 1383, https://doi.org/10.1111/liv.15875.